English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  51963005    Online Users :  1092
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

Jump to: [ Chinese Items ] [ 0-9 ] [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ]
or enter the first few letters:   

Showing items 300651-300700 of 2348419  (46969 Page(s) Totally)
<< < 6009 6010 6011 6012 6013 6014 6015 6016 6017 6018 > >>
View [10|25|50] records per page

Institution Date Title Author
中國醫藥大學 2003-07 CYP17 gene promoter allelic variant is not associated with prostate cancer 林正介(Cheng-Chieh Lin); 吳錫金(Wu,Hsi-Chin); 陳汶吉(Chen Wen-Chi); 陳慧毅(Huey-Yi Chen); 蔡輔仁(Fuu-Jen Tsai)
中國醫藥大學 2003 CYP17 gene promoter allelic variant is not associated with prostate cancer Lin, CC; Wu, HC; Chen, WC; Chen, HY; Tsai, FJ
高雄醫學大學 2006 CYP17, CYP1A1 and COMT polymorphisms and the risk of adenomyosis and endometriosis in Taiwanese women.  卓夙航;王姿乃;李昭男;吳明蒼;龍震宇;蔡英美; Juo, SH;Wang, TN;Lee, JN;Wu, MT;Long, CY;EM , Tsai
國家衛生研究院 2019-09-16 CYP17A1 maintains the survival of glioblastomas by regulating SAR1-Mediated endoplasmic reticulum health and redox homeostasis Lin, HY;Ko, CY;Kao, TJ;Yang, WB;Tsai, YT;Chuang, JY;Hu, SL;Yang, PY;Lo, WL;Hsu, TI
臺大學術典藏 2020-03-05T05:51:18Z CYP19 genetic polymorphism haplotype aasa is associated with a poor prognosis in premenopausal women with lymph node-negative, hormone receptor-positive breast cancer Kuo S.-H.; Yang S.-Y.; HUANG-CHUN LIEN; Lo C.; Lin C.-H.; Lu Y.-S.; Cheng A.-L.; Chang K.-J.; Huang C.-S.
國立臺灣大學 2013 CYP19 Genetic Polymorphism Haplotype AASA Is Associated with a Poor Prognosis in Premenopausal Women with Lymph Node-Negative, Hormone Receptor-Positive Breast Cancer Kuo, Sung-Hsin; Yang, Shi-Yi; Lien, Huang-Chun; Lo, Chiao; Lin, Ching-Hung; Lu, Yen-Sen; Cheng, Ann-Lii; Chang, King-Jeng; Huang, Chiun-Sheng; 盧彥伸; 連晃駿; 張金堅; 郭頌鑫; 鄭安理; 黃俊升; 林璟宏
臺大學術典藏 2018-09-10T09:41:56Z CYP19 genetic polymorphism haplotype aasa is associated with a poor prognosis in premenopausal women with lymph node-negative, hormone receptor-positive breast cancer Kuo, Sung-Hsin; Yang, Shi-Yi; Lien, Huang-Chun; Lo, Chiao; Lin, Ching-Hung; Lu, Yen-Sen; Cheng, Ann-Lii; Chang, King-Jeng; Huang, Chiun-Sheng; Kuo, Sung-Hsin; CHIUN-SHENG HUANG; Sung-Hsin Kuo; Lien, Huang-Chun; CHING-HUNG LIN; ANN-LII CHENG
臺大學術典藏 2020-03-23T07:19:15Z CYP19 genetic polymorphism haplotype aasa is associated with a poor prognosis in premenopausal women with lymph node-negative, hormone receptor-positive breast cancer Kuo S.-H.;Yang S.-Y.;Lien H.-C.;Lo C.;Lin C.-H.;Lu Y.-S.;Cheng A.-L.;Chang K.-J.;Chiun-Sheng Huang; Kuo S.-H.; Yang S.-Y.; Lien H.-C.; Lo C.; Lin C.-H.; Lu Y.-S.; Cheng A.-L.; Chang K.-J.; CHIUN-SHENG HUANG
臺大學術典藏 2020-05-25T06:51:55Z CYP19 genetic polymorphism haplotype aasa is associated with a poor prognosis in premenopausal women with lymph node-negative, hormone receptor-positive breast cancer Kuo S.-H;Yang S.-Y;Lien H.-C;Lo C;Lin C.-H;Yen-Shen Lu;Cheng A.-L;Chang K.-J;Huang C.-S.; Kuo S.-H; Yang S.-Y; Lien H.-C; Lo C; Lin C.-H; YEN-SHEN LU; Cheng A.-L; Chang K.-J; Huang C.-S.
臺大學術典藏 2021-09-01T01:53:43Z CYP19 genetic polymorphism haplotype aasa is associated with a poor prognosis in premenopausal women with lymph node-negative, hormone receptor-positive breast cancer Kuo S.-H.; Yang S.-Y.; Lien H.-C.; Lo C.; Lin C.-H.; Lu Y.-S.; ANN-LII CHENG; Chang K.-J.; Huang C.-S.
臺大學術典藏 2021-02-23T08:26:28Z CYP19 genetic polymorphism haplotype aasa is associated with a poor prognosis in premenopausal women with lymph node-negative, hormone receptor-positive breast cancer SUNG-HSIN KUO; Yang S.-Y.; Lien H.-C.; Lo C.; Lin C.-H.; Lu Y.-S.; Cheng A.-L.; Chang K.-J.; Huang C.-S.
臺大學術典藏 2022-08-12T06:27:39Z CYP19 genetic polymorphism haplotype aasa is associated with a poor prognosis in premenopausal women with lymph node-negative, hormone receptor-positive breast cancer Kuo S.-H.; Yang S.-Y.; Lien H.-C.; Lo C.; Lin C.-H.; Lu Y.-S.; Cheng A.-L.; KING-JEN CHANG; Huang C.-S.
中國醫藥大學 2010-07 CYP1A1 gene polymorphisms as a risk factor for pterygium (Young, C. H.); (Lo, Y. L.); 蔡宜佑(Yi-Yu Tsai); 石東生; (Lee, H.); (Cheng, Y. W.)*
國家衛生研究院 2008-09 CYP1A1 Ile462Val and GSTT1 modify the effect of cord blood cotinine on neurodevelopment at 2 years of age Hsieh, CJ;Liao, HF;Wu, KY;Hsieh, WS;Su, YN;Jeng, SF;Yu, SN;Chen, PC
國立臺灣大學 2008 CYP1A1 Ile462Val and GSTT1 modify the effect of cord blood cotinine on neurodevelopment at 2 years of age Hsieh, Chia-Jung; Liao, Hua-Fang; Wu, Kuen-Yuh; Hsieh, Wu-Shiun; Su, Yi-Ning; Jeng, Suh-Fang; Yu, Shih-Ni; Chen, Pau-Chung
臺大學術典藏 2018-09-10T06:52:37Z CYP1A1 Ile462Val and GSTT1 modify the effect of cord blood cotinine on neurodevelopment at 2 years of age Hsieh, Chia-Jung; Liao, Hua-Fang; Wu, Kuen-Yuh; Hsieh, Wu-Shiun; Su, Yi-Ning; Jeng, Suh-Fang; Yu, Shih-Ni; Chen, Pau-Chung; Hsieh, Chia-Jung; SUH-FANG JENG; WU-SHIUN HSIEH; Liao, Hua-Fang; Wu, Kuen-Yuh; KUEN-YU WU; Pau-Chung CHEN; Hsieh, Wu-Shiun; Su, Yi-Ning; Jeng, Suh-Fang; Yu, Shih-Ni; Chen, Pau-Chung
臺大學術典藏 2020-07-01T08:53:35Z CYP1A1 Ile462Val and GSTT1 modify the effect of cord blood cotinine on neurodevelopment at 2 years of age Hsieh C.-J.;Liao H.-F.;Wu K.-Y.;Hsieh W.-S.;Su Y.-N.;Suh-Fang Jeng;Yu S.-N.;Chen P.-C.; Hsieh C.-J.; Liao H.-F.; Wu K.-Y.; Hsieh W.-S.; Su Y.-N.; SUH-FANG JENG; Yu S.-N.; Chen P.-C.
臺大學術典藏 2022-03-31T02:39:48Z CYP1A1 Ile462Val and GSTT1 modify the effect of cord blood cotinine on neurodevelopment at 2 years of age Hsieh C.-J.; Liao H.-F.; Wu K.-Y.; Hsieh W.-S.; Su Y.-N.; Jeng S.-F.; Yu S.-N.; PAU-CHUNG CHEN
國立臺灣大學 2008-09 CYP1A1 Ile462Val and GSTT1 modify the effect of cord blood cotinine on neurodevelopment at two years of age Hsieh, CJ; Liao, HF; Wu, KY; Hsieh, WS; Su, YN; Jeng, SF; Yu, SN; Chen, PC
臺大學術典藏 2018-09-10T08:04:16Z CYP1A1 modifies the effect of maternal exposure to environmental tobacco smoke on child behavior Hsieh, C.-J.;Jeng, S.-F.;Su, Y.-N.;Liao, H.-F.;Hsieh, W.-S.;Wu, K.-Y.;Chen, P.-C.; SUH-FANG JENG; WU-SHIUN HSIEH; KUEN-YU WU; Pau-Chung CHEN
臺大學術典藏 2018-09-10T08:49:02Z CYP1A1 Modifies the Effect of Maternal Exposure to Environmental Tobacco Smoke on Child Behavior Pau-Chung CHEN; Hsieh, C. J.; Jeng, S. F.; Su, Y. N.; Liao, H. F.; Hsieh, W. S.; Wu, K. Y.; Chen, P. C.
臺大學術典藏 2010 CYP1A1 modifies the effect of maternal exposure to environmental tobacco smoke on child behavior Hsieh C.-J.;Suh-Fang Jeng;Su Y.-N.;Liao H.-F.;Hsieh W.-S.;Wu K.-Y.;Chen P.-C.; Hsieh C.-J.; SUH-FANG JENG; Su Y.-N.; Liao H.-F.; Hsieh W.-S.; Wu K.-Y.; Chen P.-C.
臺大學術典藏 2022-03-31T02:39:37Z CYP1A1 modifies the effect of maternal exposure to environmental tobacco smoke on child behavior Hsieh C.-J.; Jeng S.-F.; Su Y.-N.; Liao H.-F.; Hsieh W.-S.; Wu K.-Y.; PAU-CHUNG CHEN
國立臺灣大學 2010 Cyp1a1 Modifies the Effect of Maternal Exposure to Environmental Tobacco Smoke on Child Behavior at Two Years of Age 謝佳容; 鄭素芳; 蘇怡寧; 廖華芳; 謝武勳; 吳焜裕; 陳保中; HSIEH, CHIA-JUNG; JENG, SUH-FANG; SU, YI-NING; LIAO, HUA-FANG; HSIEH, WU-SHIUN; WU, KUEN-YUH; CHEN, PAU-CHUNG
中國醫藥大學 2010 CYP1A1 MspI 及GST M1基因多型性與眼翳發生的關聯 羅育倫; Yu-Lun Lo
國家衛生研究院 2008-05 CYP1A1, GSTM1, and GSTT1 polymorphisms, smoking, and lung cancer risk in a pooled analysis among Asian populations Lee, KM; Kang, D; Clapper, ML; Ingelman-Sundberg, M; Ono-Kihara, M; Kiyohara, C; Min, S; Lan, Q; Le Marchand, L; Lin, PP; Lung, ML; Pinarbasi, H; Pisani, P; Srivatanakul, P; Seow, A; Sugimura, H; Tokudome, S; Yokota, J; Taioli, E
臺大學術典藏 2000 CYP1A1,CYP2E1,COMT及MAO-B基因之多形性與巴金森氏病易感性之相關研究 吳瑞美; �d���
國立臺灣大學 2000 CYP1A1,CYP2E1,COMT及MAO-B基因之多形性與巴金森氏病易感性之相關研究 吳瑞美
高雄醫學大學 2001 CYP1A1和 SULT1A1的基因多型性與食道癌相關性之研究 何啟功
中國醫藥大學 2007-10-06 CYP1A1基因多形性與吸菸和冠狀動脈心臟病發生之相關 郭李堂; 宋鴻樟(Fung-Chang Sung); 葉志清
國家衛生研究院 2013-07 CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactions Kuo, HW;Liu, SC;Tsou, HH;Liu, SW;Lin, KM;Lu, SC;Hsiao, MC;Hsiao, CF;Liu, CY;Chen, CH;Lu, ML;Shen, WW;Tang, HS;Liu, SI;Chang, LH;Wu, HY;Chang, YS;Yeh, TK;Chen, AC;Liu, YL
臺北醫學大學 2013 CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactions HW, Kuo;SC, Liu;HH, Tsou;SW, Liu;KM, Lin;SC, Lu;MC, Hsiao;CF, Hsiao;CY, Liu;CH, Chen;ML, Lu;WW, Shen;HS, Tang;SI, Liu;LH, Chang;HY, Wu;Chang
臺北醫學大學 2013 CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactions Kuo, HW;Liu, SC;Tsou, HH;Liu, SW;Lin, KM;Lu, SC;Hsiao, MC;Hsiao, CF;Liu, CY;Chen, CH;Lu, ML;Shen, WW;Tang, HS;Liu, SI;Chang, LH;Wu, HY;Chang
臺大學術典藏 2020-02-06T08:11:28Z CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactions Kuo H.-W.;Liu S.C.;Tsou H.-H.;Liu S.-W.;Lin K.-M.;Shao-Chun Lu;Hsiao M.-C.;Hsiao C.-F.;Liu C.-Y.;Chen C.-H.;Lu M.-L.;Shen W.W.;Tang H.-S.;Liu S.-I.;Chang L.-H.;Wu H.-Y.;Chang Y.-S.;Yeh T.-K.;Chen A.C.;Liu Y.-L.; Kuo H.-W.; Liu S.C.; Tsou H.-H.; Liu S.-W.; Lin K.-M.; SHAO-CHUN LU; Hsiao M.-C.; Hsiao C.-F.; Liu C.-Y.; Chen C.-H.; Lu M.-L.; Shen W.W.; Tang H.-S.; Liu S.-I.; Chang L.-H.; Wu H.-Y.; Chang Y.-S.; Yeh T.-K.; Chen A.C.; Liu Y.-L.
國家衛生研究院 2010-11 CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine Lin, KM;Tsou, HH;Tsai IJ;Hsiao, MC;Hsiao, CF;Liu CY;Shen, WW;Tang, HS;Fang, CK;Wu, CS;Lu, SC;Kuo, HW;Liu, SC;Chan, HW;Hsu, YT;Tian, JN;Liu, YL
國立臺灣大學 2010 Cyp1a2 Genetic Polymorphisms Are Associated with Treatment Response to the Antidepressant Paroxetine 林克明; 鄒小蕙; 蕭美君; 蕭金福; 劉嘉逸; 沈武典; 湯華盛; 方俊凱; 吳其炘; 呂紹俊; 郭湘維; LIN, KEH-MING; TSOU, HSIAO-HUI; HSIAO, MEI-CHUN; HSIAO, CHIN-FU; LIU, CHIA-YIH; SHEN, WINSTON W.; TANG, HWA-SHENG; FANG, CHUN-KAI; WU, CHI-SHIN; LU, SHAO-CHUN; KUO, HSIANG-WEI; LIU, YU-LI
中國醫藥大學 2010 CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine 林克明(Keh-Ming Lin)*; 劉玉麗(Liu, Yu-Li)*
臺大學術典藏 2020-02-06T08:11:29Z CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine Hsiao M.-C.; Hsiao C.-F.; Liu C.-Y.; Shen W.W.; Tang H.-S.; Fang C.-K.; Wu C.-S.; SHAO-CHUN LU; Kuo H.-W.; Liu S.C.; Chan H.-W.; Hsu Y.-T.; Tian J.-N.; Liu Y.-L.; Lin K.-M.;Tsou H.-H.;Tsai I.-J.;Hsiao M.-C.;Hsiao C.-F.;Liu C.-Y.;Shen W.W.;Tang H.-S.;Fang C.-K.;Wu C.-S.;Shao-Chun Lu;Kuo H.-W.;Liu S.C.;Chan H.-W.;Hsu Y.-T.;Tian J.-N.;Liu Y.-L.; Lin K.-M.; Tsou H.-H.; Tsai I.-J.
臺大學術典藏 2010 CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine Lin K.-M.; Tsou H.-H.; Tsai I.-J.; Hsiao M.-C.; Hsiao C.-F.; Liu C.-Y.; Shen W.W.; Tang H.-S.; Fang C.-K.; CHI-SHIN WU; Lu S.-C.; Kuo H.-W.; Liu S.C.; Chan H.-W.; Hsu Y.-T.; Tian J.-N.; Liu Y.-L.
國家衛生研究院 2012-03 CYP1A2 genetic polymorphisms associated with antidepressant escitalopram metabolism and adverse reactions at early stage Liu, Y;Tian, J;Kuo, H;Tsou, H;Liu, S;Lu, S;Lin, K;Chen, Y
國立中山大學 2013-07-23 CYP26B1 及相關蛋白質在檳榔引發口腔癌之研究 許正傑
高雄醫學大學 2012 CYP27A1 polymorphism 與有代謝症候群男性之脂肪激素和膽固醇代謝顯著相關  鄭凱鴻;劉家駒;黃俊農;李永進;朱志生;眭致遠;賴文德;黃書彬 
高雄醫學大學 2012 CYP27A1 polymorphism 與有代謝症候群男性之脂肪激素和膽固醇代謝顯著相關  鄭凱鴻;劉家駒;黃俊農;李永進;朱志生;眭致遠;賴文德;黃書彬 
臺北醫學大學 2004 CYP2B1/2 contributes to propofol metabolism to 4-hydroxy-propofol in rat liver. 陳瑞明; Lin YL; Chen TL; Chen RM;
國家衛生研究院 2011-08 CYP2B6 polymorphisms influence the plasma concentration and clearance of the methadone S-enantiomer Wang, SC;Ho, IK;Tsou, HH;Tian, JN;Hsiao, CF;Chen, CH;Tan, HK;Lin, L;Wu, CS;Su, LW;Huang, CL;Yang, YH;Liu, ML;Lin, KM;Chen, CY;Liu, SC;Wu, HY;Chan, HW;Tsai, MH;Lin, PS;Liu, YL
中國醫藥大學 2011-08 CYP2B6 Polymorphisms Influence the Plasma Concentration and Clearance of the Methadone S-Enantiomer (Wang SC);(Ho IK);(Tsou HH);(Tian JN);(Hsiao CF);(Chen CH);(Tan HK);(Lin L);(Wu CS);(Su LW);黃介良(Chieh-Liang Huang);(Yang YH);(Liu ML);(Lin KM);(Chen CY);(Liu SC);(Wu HY);(Chan HW);(sai MH);(Lin PS);(Liu YL)*
臺大學術典藏 2020-11-04T09:17:20Z CYP2B6 polymorphisms influence the plasma concentration and clearance of the methadone S-enantiomer Wang S.-C.; Ho I.-K.; Tsou H.-H.; Tian J.-N.; Hsiao C.-F.; Chen C.-H.; Tan H.K.-L.; Lin L.; CHI-SHIN WU; Su L.-W.; Huang C.-L.; Yang Y.-H.; Liu M.-L.; Lin K.-M.; Chen C.-Y.; Liu S.C.; Wu H.-Y.; Chan H.-W.; Tsai M.-H.; Lin P.-S.; Liu Y.-L.
國立成功大學 2008-08 CYP2C19 genotypes and Helicobacter pylori eradication Sheu, Bor-Shyang; Fock, Kwong-Ming
國立成功大學 2012-01 CYP2C19 genotypes determine the efficacy of on-demand therapy of pantoprazole for reflux esophagitis as Los-Angeles grades C and D Sheu, Bor-Shyang; Cheng, Hsiu-Chi; Yeh, Yi-Chun; Chang, Wei-Lun
臺大學術典藏 2018-09-10T08:02:38Z CYP2C19 genotypes in the pharmacokinetics/pharmacodynamics of proton pump inhibitor-based therapy of Helicobacter pylori infection Yang, J.-C.;Lin, C.-J.; CHUN-JUNG LIN; JYH-CHIN YANG

Showing items 300651-300700 of 2348419  (46969 Page(s) Totally)
<< < 6009 6010 6011 6012 6013 6014 6015 6016 6017 6018 > >>
View [10|25|50] records per page